PMID: 7010522Jan 1, 1980Paper

The effect of topical N-acetyl-5-aminosalicylic acid in ulcerative colitis

Scandinavian Journal of Gastroenterology
C P WilloughbyS C Truelove

Abstract

In a double-blind controlled therapeutic trial, retention enemas of N-acetyl-5-aminosalicylic acid (Ac-5-ASA) were compared with dummy enemas in the treatment of active ulcerative colitis. Forty patients were studied, each patient taking one test enema twice a day for 2 weeks. Seventeen of the patients had a mild clinical attack of the disease; the 23 others had sigmoidoscopic evidence of active inflammation although they were in clinical remission. Histological and sigmoidoscopic improvement were significantly commoner in the patients receiving the active treatment than in those taking the dummy preparation. Pronounced histological improvement was only seen in patients taking the Ac-5-ASA enemas. In those patients who had clinical attacks of ulcerative colitis at the start of the study, symptomatic improvement was commoner in the group treated with Ac-5-ASA enemas than in those who received placebo therapy. Ac-5-ASA resembles 5-aminosalicylic acid in its effect on the inflamed mucosa in ulcerative colitis. Further studies into other substituted salicylates may lead to the development of an effective oral agent that does not carry the side effects associated with the sulphapyridine moiety of sulphasalazine.

References

Nov 1, 1976·Clinical Pharmacokinetics·K M Das, R Dubin
Feb 4, 1978·Lancet·P A van HeesH J van Lier
Jul 1, 1972·Clinical Pharmacology and Therapeutics·H Schröder, D E Campbell

❮ Previous
Next ❯

Citations

Jul 1, 1987·Digestive Diseases and Sciences·J GandolfoM Kaplan
Dec 1, 1987·Digestive Diseases and Sciences·M S McPheeN J Greenberger
Jan 1, 1990·Pharmacology & Therapeutics·K F IlettR F Minchin
Aug 1, 1994·Pharmacology & Therapeutics·S P Travis, D P Jewell
Sep 1, 1992·British Journal of Clinical Pharmacology·B Crotty, D P Jewell
Nov 16, 1985·British Medical Journal·W S SelbyD P Jewell
Jan 1, 1992·European Journal of Clinical Pharmacology·R A van HogezandJ H van Tongeren
Jan 1, 1983·European Journal of Clinical Pharmacology·C FischerU Klotz
Jun 7, 2013·The Journal of Pharmacy and Pharmacology·Jun KamishikiryoNarumi Sugihara
Oct 1, 1984·British Journal of Clinical Pharmacology·C O MeeseU Klotz
Dec 1, 1983·British Journal of Clinical Pharmacology·O Haagen Nielsen, S Bondesen
Aug 11, 1992·The American Journal of Medicine·D L Geier, P B Miner
Jan 22, 2010·The Cochrane Database of Systematic Reviews·John K MarshallE Jan Irvine
Jan 1, 1988·Scandinavian Journal of Gastroenterology. Supplement·R A van Hogezand
Apr 20, 2014·American Journal of Physiology. Gastrointestinal and Liver Physiology·Verónica Ramírez-Alcántara, Marshall H Montrose
Nov 1, 1992·Scandinavian Journal of Gastroenterology·R EliakimD Rachmilewitz
Jan 1, 1988·Scandinavian Journal of Gastroenterology. Supplement·D J HetzelR Rowland
May 1, 1983·Scandinavian Journal of Gastroenterology·H Sandberg-GertzénG Järnerot
Jan 1, 1983·Scandinavian Journal of Gastroenterology·H Sandberg-GertzénG Järnerot
Jan 1, 1987·Acta Medica Scandinavica·S BondesenE F Hvidberg
May 1, 1983·Pharmacotherapy·D M Sack, M A Peppercorn
Aug 1, 1993·Alimentary Pharmacology & Therapeutics·S M GreenfieldR P Thompson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.